Add BrightSurf on Google Email

Science News for October 15, 2002


Researchers track elusive brain tumor cells in mice with neural stem cells modified to deliver IL-12

Scientists have developed a novel treatment using neural stem cells to track and target brain tumor cells that spread into normal brain tissue. The therapy involves genetically engineering neural stem cells to produce interleukin 12, an immune-stimulating chemical known to kill glioma cells. Mice treated with this approach survived sig...

SourceCedars-Sinai Medical Center·JournalCancer Research·DateOct 15, 2002

Breast cancer risk overestimated by women, says University of Toronto study

A University of Toronto study reveals that women who undergo prophylactic bilateral mastectomy significantly overestimate their breast cancer risk, except for those with BRCA1 and BRCA2 mutations. The study suggests that formal genetic counselling is essential for women considering the procedure to make an informed decision.

SourceUniversity of Toronto·JournalJNCI Journal of the National Cancer Institute·DateOct 15, 2002

Exposure to atomic bomb radiation associated with nervous system tumors

A study of Japanese atomic bomb survivors found a significant association between radiation exposure and an increased risk of all nervous system tumors, with higher risks for schwannomas, men, and children. The authors suggest that these increased risks persist throughout lifetime, regardless of age at exposure.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateOct 15, 2002

Other highlights in the October 16 issue of JNCI

A study in the Journal of the National Cancer Institute found that women undergoing prophylactic bilateral mastectomy often overestimate their breast cancer risk. Meanwhile, a separate study uncovered no association between antiperspirant use and increased breast cancer risk. Furthermore, researchers identified a serum protein expressi...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateOct 15, 2002